Nova Patents
PL355470A1

Application of analgesic peptides as an active substance in the equipment designed to administer medicine in the place where it is expected to bring relief

Abstract

Provided are compounds represented by: wherein R1 is a D-alanine, D-serine, D-threonine, D-methionine, D-leucine, D-asparagine or D-glutamine side chain and R2 is a phenylalanine or tryptophan side-chain, and compositions containing such compounds.

Term

Term ended

Projected expiry passed 13 August 2022, 4.1 years ago.

  1. Priority and filed
  2. Published
  3. Projected expiry
  4. Today

18 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
35547002PolandA
02355470–––
PL20020355470–––

Members18

Family members, oldest first
DocumentOfficeKind
WO2004014943A2World Intellectual Property Organization (WIPO)A2
PL355470A1This recordPolandA1
AU2003272160A1AustraliaA1
AU2003272160A8AustraliaA8
WO2004014943A3World Intellectual Property Organization (WIPO)A3
EP1529057A2European Patent Office (EPO)A2
US2006241053A1United States of AmericaA1
EP1529057B1European Patent Office (EPO)B1
AT395354TAustriaT
ATE395354T1AustriaT1
DE60320999D1GermanyD1
PT1529057EPortugalE
DK1529057T3DenmarkT3
SI1529057T1SloveniaT1
ES2306885T3SpainT3
PL205811B1PolandB1
US8084429B2United States of AmericaB2
CY1110890T1CyprusT1